Tsu-Hui Lin
Pediatric Endocrinology · Tampa, FLNPI 1760460992
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $767, 4.2 times the $183 reported in 2019.
Across 123 payments — averaging $21.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$393
- Dexcom, Inc.$260
- Novo Nordisk$242
- Pfizer$164
- Abbott$152
- Ascendis Pharma Endocrinology Inc$144
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,62898%
- Education$662%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $393 |
| Dexcom, Inc. | 12 | $260 |
| Novo Nordisk | 13 | $242 |
| Pfizer | 9 | $164 |
| Abbott | 8 | $152 |
| Ascendis Pharma Endocrinology Inc | 6 | $144 |
| Insulet Corporation | 7 | $141 |
| Eton Pharmaceuticals, Inc. | 3 | $125 |
| Sanofi-aventis U.S. LLC | 4 | $105 |
| Neurocrine Biosciences, Inc. | 4 | $105 |
| Tolmar Pharmaceuticals, Inc. | 5 | $104 |
| Lifescan, Inc. | 5 | $97 |
| Azurity Pharmaceuticals, Inc. | 4 | $84 |
| Sequel Med Tech, LLC | 2 | $82 |
| Sanofi | 3 | $70 |
| Tolmar, Inc. | 3 | $64 |
| BETA Bionics, Inc. | 3 | $61 |
| Biomarin Pharmaceutical Inc. | 2 | $48 |
| Xeris Pharmaceuticals, Inc. | 3 | $48 |
| Endo USA, Inc. | 1 | $27 |
| Chiesi USA, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $21 |
| Rhythm Pharmaceuticals, Inc. | 1 | $20 |
| Zealand Pharma US, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Soleno Therapeutics, Inc. | 1 | $19 |
| Tandem Diabetes Care, Inc. | 1 | $17 |
| Medtronic | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lupron Depot$121
How this compares
$2,693 in reported general payments places this provider in the 60th percentile of 102 pediatric endocrinology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metformin Hcl ErMetformin Hcl | 11 | $34 |
Paid to pharmacies, not to this prescriber.
Other pediatric endocrinology in Tampa
- Henry RodriguezTampa$211K
- Dorothy ShulmanTampa$104K
- Danielle ReynoldsTampa$8K
- Terry DeclueTampa$6K
- Grace DouganTampa$6K
- Joshua YangOrlando$846K
- Michael HallerGainesville$102K
- Alejandro DiazMiami$101K
- Samuel FreedmanPembroke Pines$71K
- Jennifer MillerGainesville$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.